Clinical trial
12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional…
NCT00252993 · Dynogen Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00252993 |
|---|---|
| Title | 12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DDP225 in Patients With Chronic Functional Vomiting |
| Lead sponsor | Dynogen Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Vomiting |
| Intervention type | Drug |
| Interventions | DDP225 |
| Enrollment | 30 |
| Start date | Nov 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Nov 15, 2005 |
| Last update posted | Oct 12, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: